Carole Ho - Net Worth and Insider Trading
Carole Ho Net Worth
The estimated net worth of Carole Ho is at least $8 Million dollars as of 2024-11-29. Carole Ho is the Chief Medical Officer of Denali Therapeutics Inc and owns about 327,029 shares of Denali Therapeutics Inc (DNLI) stock worth over $8 Million. Details can be seen in Carole Ho's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carole Ho has not made any transactions after 2024-08-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Carole Ho
Carole Ho Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carole Ho owns 3 companies in total, including Denali Therapeutics Inc (DNLI) , NGM Biopharmaceuticals Inc (NGM) , and Beam Therapeutics Inc (BEAM) .
Click here to see the complete history of Carole Ho’s form 4 insider trades.
Insider Ownership Summary of Carole Ho
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DNLI | Denali Therapeutics Inc | 2024-08-21 | Chief Medical Officer |
| NGM | NGM Biopharmaceuticals Inc | 2020-06-05 | director |
| BEAM | Beam Therapeutics Inc | 2020-02-05 | director |
Carole Ho Latest Holdings Summary
Carole Ho currently owns a total of 1 stock. Carole Ho owns 327,029 shares of Denali Therapeutics Inc (DNLI) as of August 21, 2024, with a value of $8 Million.
Latest Holdings of Carole Ho
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DNLI | Denali Therapeutics Inc | 2024-08-21 | 327,029 | 25.16 | 8,228,050 |
Holding Weightings of Carole Ho
Carole Ho Form 4 Trading Tracker
According to the SEC Form 4 filings, Carole Ho has made a total of 30 transactions in Denali Therapeutics Inc (DNLI) over the past 5 years, including 0 buys and 30 sells. The most-recent trade in Denali Therapeutics Inc is the sale of 22,458 shares on August 21, 2024, which brought Carole Ho around $549,996.
Insider Trading History of Carole Ho
- 1
Carole Ho Trading Performance
Carole Ho Ownership Network
Carole Ho Owned Company Details
What does Denali Therapeutics Inc do?
Who are the key executives at Denali Therapeutics Inc?
Carole Ho is the Chief Medical Officer of Denali Therapeutics Inc. Other key executives at Denali Therapeutics Inc include COO and Secretary Alexander O. Schuth , director & President and CEO Ryan J. Watts , and CFO and Treasurer Steve E. Krognes .
Denali Therapeutics Inc (DNLI) Insider Trades Summary
Over the past 18 months, Carole Ho made 9 insider transaction in Denali Therapeutics Inc (DNLI) with a net sale of 54,249. Other recent insider transactions involving Denali Therapeutics Inc (DNLI) include a net sale of 29,606 shares made by Vicki L Sato , a net sale of 89,326 shares made by Alexander O. Schuth , and a net sale of 131,985 shares made by Ryan J. Watts .
In summary, during the past 3 months, insiders sold 153,199 shares of Denali Therapeutics Inc (DNLI) in total and bought 0 shares, with a net sale of 153,199 shares. During the past 18 months, 528,357 shares of Denali Therapeutics Inc (DNLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 528,357 shares.
Denali Therapeutics Inc (DNLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Denali Therapeutics Inc Insider Transactions
Carole Ho Mailing Address
Above is the net worth, insider trading, and ownership report for Carole Ho. You might contact Carole Ho via mailing address: C/o Denali Therapeutics Inc., 151 Oyster Point Blvd., 2nd Floor, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
